Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2021-09-30 Regulatory Filings
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Approval and Publication of Prospectus
Regulatory Filings Classification · 98% confidence The document is an RNS announcement from Oxford Nanopore Technologies plc dated September 30, 2021. The core subject is the 'Approval and Publication of Prospectus' in connection with its Initial Public Offering (IPO) and proposed admission to the London Stock Exchange. It explicitly states that the Prospectus is expected to be published today and directs readers to the final Prospectus for investment decisions, while clarifying that this announcement itself is not the prospectus. This fits the definition of a Report Publication Announcement (RPA) because it announces the publication of a major document (the Prospectus) rather than being the comprehensive report itself (like a 10-K or IR). Since it is a formal announcement regarding the release of a key regulatory/offering document, RPA is the most precise fit, although RNS is also plausible as a general regulatory filing. Given the specific focus on the publication of the Prospectus, RPA is preferred over the general RNS fallback.
2021-09-30 English
Announcement of Offer Price
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement from Oxford Nanopore Technologies plc dated September 30, 2021. It explicitly discusses the pricing of its Initial Public Offering (IPO) at 425 pence per share, the total market capitalization (£3.4 billion), the number of new and existing shares being offered, and the expected dates for conditional and unconditional dealings on the London Stock Exchange. This content is directly related to a major capital raising and listing event. While it mentions a Prospectus is expected to be published later today, the announcement itself is the official regulatory notification regarding the pricing and size of the offering. This falls under the category of financing activities. The most specific code for fundraising/financing activities is 'CAP' (Capital/Financing Update). It is not the full prospectus (10-K/IR), nor is it just a general regulatory filing (RNS) given the specific financial nature of the announcement.
2021-09-30 English
[accounts-balance-sheet]
Regulatory Filings
2021-09-24 English
Intention to Float
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement from Oxford Nanopore Technologies Ltd. dated September 16, 2021. The key phrases are "Confirmation of Intention to Float on the London Stock Exchange," "IPO," and details about the Offer Price, cornerstone investment, and application for admission to listing. This document is announcing a major capital raising and listing event, which falls under the category of financing activities. While it relates to an upcoming offering (which might involve a prospectus), the document itself is the official announcement confirming the intention to float and providing key details. This aligns best with the Capital/Financing Update (CAP) category, as it details the structure and intent of the IPO fundraising. It is not the final prospectus, nor is it a general regulatory filing (RNS) since it is highly specific to capital raising.
2021-09-16 English
Oxford Nanopore Technologies Limited - Registration document
Regulatory Filings Classification · 95% confidence The document is a 'Registration Document' for Oxford Nanopore Technologies Limited, prepared in accordance with the Prospectus Regulation Rules of the UK Financial Conduct Authority. It contains detailed business descriptions, risk factors, historical financial information, and governance details. This type of document is a formal regulatory filing required for companies preparing for an IPO or listing, which falls under the 'Regulatory Filings' category as it is a comprehensive legal disclosure document that does not fit into the specific periodic report categories like 10-K or IR.
2021-09-13 English
Publication of Registration Document
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Oxford Nanopore Technologies Ltd. dated September 10, 2021. The key content is the confirmation that the 'Registration Document relating to the Company has received approval from the UK Financial Conduct Authority and has been published on the Company's website' in connection with a potential Initial Public Offering (IPO). It explicitly states that this announcement is not a prospectus and directs investors to the final Prospectus if published. Since the document's primary function is to announce the publication/approval of a key regulatory document (the Registration Document) related to a capital market event (IPO), and it is distributed via RNS, it fits the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of announcing the publication of a document related to an offering, RPA is highly appropriate, but RNS is the general regulatory announcement category. Since the document itself is the announcement of the publication of the Registration Document, and it is clearly marked with an RNS Number, classifying it as RNS (Regulatory Filings) is the most accurate general fit, although RPA is also very close. I will select RNS as the primary category for regulatory news releases.
2021-09-10 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.